Sequenta Introduces ClonoSIGHT, Sequencing-Based MRD Test for Leukemia, Lymphoma
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read More
Search Results for: leukemia
Emerging Technologies: NGS Gains Foothold
As the potential use and benefit of next-gen sequencing becomes more evident, the arrival of this emerging technology and the resulting paradigm shift seem imminent.
Read More
Trovagene Grants License for Marker for AML to Duke
Clinical labs have been interested in licensing the assay so they can offer it to physicians for use in patient care.
Read More
Adaptive Introduces Assay to Detect MRD in Blood-Based Cancers
Adaptive will accept clinical samples in its CLIA certified, state-of-the-art immune repertoire sequencing laboratory in 2013
Read More
54th ASH Annual Meeting to Showcase Leading-Edge Hematology Research, Education, Patient Care
The American Society of Hematology will host approximately 20,000 attendees from around the world at its 54th annual meeting and exposition, December 8 to December 11, at the Georgia World Congress Center in Atlanta.
Read More